Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
SURPASS-2 directly compared tirzepatide 15 mg to semaglutide 1 mg over 40 weeks
Individuals with type 2 diabetes and obesity face a high risk for developing cardiovascular disease and experiencing major cardiac events or conditions, including myocardial infarction, stroke, heart failure, cardiovascular death, and peripheral arterial disease
After injecting, gently press the site with a clean tissue or cotton pad for a few seconds
After three months of using the drug, she has lost 7 pounds
Understanding the scientific basis of these injections helps in assessing their potential role in weight management
